N/A
N=8,202
HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University
HIV · AIDS
Bottom Line
View on ClinicalTrials.gov: NCT01339416 ↗Enrolled (actual)
8,202
Serious AEs
—
Results posted
Apr 2014
Primary outcome: Primary: Incidence Rate of Malignancies — 0.30; 0.27; 0.02; 0.62 malignancies per 100 person-years
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- ViiV Healthcare
- Primary completion
- May 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence Rate of Malignancies |
0.30; 0.27; 0.02; 0.62 | — |
| PRIMARY Incidence Rate of Acquired Immunodeficiency Syndrome (AIDS)-Defining Opportunistic Infections |
2.04; 1.72; 0.77; 0.66; 0.38; 0.37 | — |
| PRIMARY Incidence Rate of Myocardial Infarction |
0.27 | — |
| PRIMARY Incidence Rate of Liver Failure |
0.16 | — |
| PRIMARY Incidence Rate of Viral Encephalitis |
0.003 | — |
| SECONDARY Incidence Rate of Rhabdomyolysis |
0.10 | — |
| SECONDARY Incidence Rate of Death |
3.81 | — |
Summary
Human Immunodeficiency Virus (HIV) infected patients in the HIV registries of Johns Hopkins University, University of North Carolina and Vanderbilt University will be followed in the routine clinical care to estimate the rates of prespecified clinical events in this population.
Eligibility Criteria
Inclusion Criteria
- HIV infection.
Exclusion Criteria
- None.
Data sourced from ClinicalTrials.gov (NCT01339416). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.